🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Many congratulations Paul Dark . Fantastic achievement. Well done ADAPT-Sepsis and Warwick CTU Can't wait to hear about the findings

Paul Dark ADAPT-Sepsis NCA Research NHS Wei-Chun Tu UoM Biology, Medicine and Health Congratulations Paul, and all who participated 🌟

Paul Dark ADAPT-Sepsis NCA Research NHS Wei-Chun Tu UoM Biology, Medicine and Health Congratulations

Paul Dark ADAPT-Sepsis NCA Research NHS Wei-Chun Tu UoM Biology, Medicine and Health Fantastic achievement 👏 Looking forward to the results and how they will guide AMS practice in the critically ill

Paul Dark ADAPT-Sepsis NCA Research NHS Wei-Chun Tu UoM Biology, Medicine and Health Incredible work by ADAPT-Sepsis team and Paul Dark !

Paul Dark ADAPT-Sepsis NCA Research NHS Wei-Chun Tu UoM Biology, Medicine and Health Amazing!! Well done xx

Paul Dark ADAPT-Sepsis NCA Research NHS Wei-Chun Tu UoM Biology, Medicine and Health Congratulations, Paul, looking forward to the results!

Great work to all involved in completing recruitment to the ADAPT-Sepsis study. Thank you to our research team for their hard work in recruiting 85 of the number below! NCA Research NHS Oldham Care Organisation

Thrilled to hear that the ADAPT-Sepsis team have reached their recruitment target - well done everyone! We're looking forward to comparing our process evaluation findings with your trial results in the coming months! cedar.nhs.wales/our-work/clini…

From Belfast to Melbourne - CCR Down Under is coming The Best Critical Care Trials in the World #CCRdownunder criticalcarereviews.com/meetings/ccr-d… INTENSIVE - The Alfred ICU Chris Nickson @precordialthump.bsky.social Kirsten Bibbins-Domingo Giovanni Landoni, MD Giacomo Monti Martina Baiardo Redaelli ANZICS Clinical Trials Group Prof Carol Hodgson Paul Young

We're delighted to announce ADAPT-Sepsis as our first trial result presentation at #CCRdownunder ADAPT-Sepsis is a 2760 patient RCT investigating biomarker-guided duration of antibiotic therapy in patients with sepsis To be presented by Paul Dark criticalcarereviews.com/meetings/ccr-d…

Fantastic work led by Paul Dark and delivered by the phenomenal UK Critical Care community. We can safely reduce antibiotic duration using procalcitonin (but not CRP). ADAPT-Sepsis Warwick CTU

We are delighted to have contributed to this important trial. Because clinical research is how we improve the care we deliver. Thank you to our patients who took part. ADAPT-Sepsis NCA Research NHS Paul Dark

Chief Investigator Paul Dark shares the findings from the #ADAPTsepsistrial at #CCRdownunder ADAPT-Sepsis UoM Biology, Medicine and Health National Institute for Health and Care Research EPPiC Warwick NCA Research NHS JAMA

Paul Dark presents the results of the ADAPT-Sepsis trial results earlier today at @CCRdownunder The paper has been published in JAMA jamanetwork.com/journals/jama/…

A major UK patient trial of a new biomarker testing protocol for sepsis, led by The University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current care 🔬 UoM Biology, Medicine and Health Paul Dark Read more about the trial 👇 manchester.ac.uk/about/news/bio…

1/ Delighted to report the results of the Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH) trial in The Lancet Child & Adolescent Health thelancet.com/journals/lanch…

The Bottom Line hrishee Thank you for this detailed review and comments. We ADAPT-Sepsis are working on trial process evaluation and health economic outcomes right now, so more to come to aid understanding of results. Hopefully, we will see you all Intensive Care Society 💙 events in 2025 for further discussions

Editor’s choice from the February 25 issue. ➡️ Camrelizumab With Chemotherapy in Patients With Early or Locally Advanced TNBC ➡️ Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis ➡️ Essential Thrombocythemia: A Review; and more.

Delighted to have the chance to address important international discussions about ADAPT-Sepsis jamanetwork.com/journals/jama/…